BACKGROUND: Findings from postmortem studies suggest reduced prefrontal cortical thickness in schizophrenia; however, cortical thickness in first-episode schizophrenia has not been evaluated using magnetic resonance imaging (MRI). METHODS: Prefrontal cortical thickness was measured using MRI in first-episode schizophrenia patients (n = 17), first-episode affective psychosis patients (n = 17), and normal control subjects (n = 17); subjects were age-matched within 2 years and within a narrow age range (18-29 years). A previous study using the same subjects reported reduced prefrontal gray matter volume in first-episode schizophrenia. Manual editing was performed on those prefrontal segmentations before cortical thickness was measured. RESULTS: Prefrontal cortical thickness was not significantly different among groups. Prefrontal gray matter volume and thickness were, however, positively correlated in both schizophrenia and control subjects. The product of boundary complexity and thickness, an alternative measure of volume, was positively correlated with volume for all three groups. Finally, age and age at first medication were negatively correlated with prefrontal cortical thickness only in first-episode schizophrenia. CONCLUSIONS: This study demonstrates the potential usefulness of MRI for the study of cortical thickness abnormalities in schizophrenia. Correlations between cortical thickness and age and between cortical thickness and age at first medication suggest that the longer the schizophrenic process has been operative, the thinner the prefrontal cortex, although this needs confirmation in a longitudinal study.
BACKGROUND: Findings from postmortem studies suggest reduced prefrontal cortical thickness in schizophrenia; however, cortical thickness in first-episode schizophrenia has not been evaluated using magnetic resonance imaging (MRI). METHODS: Prefrontal cortical thickness was measured using MRI in first-episode schizophreniapatients (n = 17), first-episode affective psychosispatients (n = 17), and normal control subjects (n = 17); subjects were age-matched within 2 years and within a narrow age range (18-29 years). A previous study using the same subjects reported reduced prefrontal gray matter volume in first-episode schizophrenia. Manual editing was performed on those prefrontal segmentations before cortical thickness was measured. RESULTS: Prefrontal cortical thickness was not significantly different among groups. Prefrontal gray matter volume and thickness were, however, positively correlated in both schizophrenia and control subjects. The product of boundary complexity and thickness, an alternative measure of volume, was positively correlated with volume for all three groups. Finally, age and age at first medication were negatively correlated with prefrontal cortical thickness only in first-episode schizophrenia. CONCLUSIONS: This study demonstrates the potential usefulness of MRI for the study of cortical thickness abnormalities in schizophrenia. Correlations between cortical thickness and age and between cortical thickness and age at first medication suggest that the longer the schizophrenic process has been operative, the thinner the prefrontal cortex, although this needs confirmation in a longitudinal study.
Authors: Y Hirayasu; S Tanaka; M E Shenton; D F Salisbury; M A DeSantis; J J Levitt; C Wible; D Yurgelun-Todd; R Kikinis; F A Jolesz; R W McCarley Journal: Cereb Cortex Date: 2001-04 Impact factor: 5.357
Authors: E V Sullivan; K O Lim; D Mathalon; L Marsh; D M Beal; D Harris; A L Hoff; W O Faustman; A Pfefferbaum Journal: Cereb Cortex Date: 1998-03 Impact factor: 5.357
Authors: Laura C Wiegand; Simon K Warfield; James J Levitt; Yoshio Hirayasu; Dean F Salisbury; Stephan Heckers; Sylvain Bouix; Daniel Schwartz; Magdalena Spencer; Chandlee C Dickey; Ron Kikinis; Ferenc A Jolesz; Robert W McCarley; Martha E Shenton Journal: Am J Psychiatry Date: 2005-01 Impact factor: 18.112
Authors: Antonio Y Hardan; Sri Muddasani; Madhuri Vemulapalli; Matcheri S Keshavan; Nancy J Minshew Journal: Am J Psychiatry Date: 2006-07 Impact factor: 18.112
Authors: Carolina Makowski; John D Lewis; Claude Lepage; Ashok K Malla; Ridha Joober; Martin Lepage; Alan C Evans Journal: Cereb Cortex Date: 2019-12-17 Impact factor: 5.357
Authors: Nitin Gogtay; Brian Weisinger; Jennifer L Bakalar; Reva Stidd; Oscar Fernandez de la Vega; Rachel Miller; Liv Clasen; Deanna Greenstein; Judith L Rapoport Journal: Schizophr Res Date: 2012-07-24 Impact factor: 4.939
Authors: John F Smiley; Gorazd Rosoklija; Branislav Mancevski; J John Mann; Andrew J Dwork; Daniel C Javitt Journal: Eur J Neurosci Date: 2009-07-28 Impact factor: 3.386
Authors: Heekyung Lee; Dino Dvorak; Hsin-Yi Kao; Áine M Duffy; Helen E Scharfman; André A Fenton Journal: Neuron Date: 2012-08-23 Impact factor: 17.173